{"id":799929,"date":"2026-07-14T15:15:14","date_gmt":"2026-07-14T15:15:14","guid":{"rendered":"https:\/\/www.newsbeep.com\/au\/799929\/"},"modified":"2026-07-14T15:15:14","modified_gmt":"2026-07-14T15:15:14","slug":"novel-vaccine-framework-illustrates-promise-for-oral-cancer-vaccines-news","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/au\/799929\/","title":{"rendered":"Novel vaccine framework illustrates promise for oral cancer vaccines | News"},"content":{"rendered":"<p class=\"picture\"><img fetchpriority=\"high\" decoding=\"async\" alt=\"bifidobacterium-gut-health\" src=\"https:\/\/www.newsbeep.com\/au\/wp-content\/uploads\/2026\/07\/21696_shutterstock_2482770711_757228.jpg\"   loading=\"eager\" class=\"lazyloaded\" width=\"1000\" height=\"623\"\/><\/p>\n<p>Genetically engineered Bifidobacterium longum could enhance anti-tumour immunity, new research shows.<\/p>\n<p>Leveraging a novel vaccine platform, the study by\u00a0joint research team from Tokushima University, Hiroshima University and Hamamatsu University in Japan,\u00a0highlight <a href=\"https:\/\/www.europeanpharmaceuticalreview.com\/topics\/formulation-and-drug-delivery\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">oral cancer vaccines<\/a> as a new component of combination cancer immunotherapy.<\/p>\n<p>Bifidobacterium was chosen due to its capacity to interact with the gut\u2019s immune system to display a much larger portion of a modified WT1 protein.<\/p>\n<p>After altering the bacterium, the team\u00a0evaluated the resulting oral vaccine B440 in a Phase I trial. This involved 12 patients with metastatic urothelial cancer who had exhausted standard treatment options.<\/p>\n<p>WT1-specific cellular immune responses were detected in six patients. While they previously had weak responses prior to treatment, they remained progression-free for longer than the other patients. In the remaining six patients, who had no detectable preexisting response, B440 induced a new WT1-specific immune response.<\/p>\n<p>Post-trial, seven patients received an additional round of the immune checkpoint inhibitor pembrolizumab. In three of these patients, tumour shrinkage was observed. They demonstrated detectable WT1-specific cellular immune responses following B440.<\/p>\n<p>Based on this data, B440 may act more as an immune enhancer than as an initiator of immunity. If this outcome is clinically confirmed, a low-level preexisting immune response to WT1 could become a biomarker candidate for those with a higher likelihood of benefitting from B440 or similar cancer immunotherapies.<\/p>\n<p>Only one treatment-related adverse event was observed\u2014a mild reaction involving a transient increase in interleukin-6 (IL-6), in three patients.<\/p>\n<p>Kobe University translational cancer researcher, Shirakawa Toshiro said: \u201cWe need new approaches that can safely enhance anti-tumour immunity and complement immune checkpoint inhibitors.<\/p>\n<p>\u201cMany oral vaccines currently in use are designed to prevent infectious diseases and are based on attenuated or inactivated forms of enteric pathogens. However, developing a safe and versatile oral platform capable of delivering a selected antigen protein, such as a cancer antigen, to gut-associated lymphoid tissue remains a major challenge.\u201d<\/p>\n<p>&#13;<\/p>\n<p>\u201cDeveloping a safe and versatile oral platform capable of delivering a selected antigen protein, such as a cancer antigen, to gut-associated lymphoid tissue remains a major challenge\u201d<\/p>\n<p>&#13;<\/p>\n<p class=\"quotesource\">\u00a0Shirakawa Toshiro,\u00a0Kobe University<\/p>\n<p>&#13;<\/p>\n<p>However, due to the small-scale nature of the study, B440\u2019s contribution to these responses cannot be fully verified and should be taken as \u201cexploratory and hypothesis-generating\u201d. Shirakawa added: \u201cAs this was a small, single-arm phase I trial, it was not designed to establish efficacy\u201d.<\/p>\n<p>Looking ahead, a Phase I\/II trial of B440 is ongoing, in combination with the immune checkpoint inhibitors nivolumab and ipilimumab in non-removable malignant pleural mesothelioma.<\/p>\n<p>In conclusion, according to Shirakawa, the research represents the \u201cnext step toward evaluating orally administered cancer vaccines as a new component of combination cancer immunotherapy\u201d.<\/p>\n<p>The paper was published in <a class=\"external\" href=\"https:\/\/ascopubs.org\/doi\/10.1200\/OA-25-00153\" target=\"_blank\" rel=\"nofollow noopener\">JCO Oncology Advances<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"Genetically engineered Bifidobacterium longum could enhance anti-tumour immunity, new research shows. Leveraging a novel vaccine platform, the study&hellip;\n","protected":false},"author":2,"featured_media":799930,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10],"tags":[64,63,137],"class_list":["post-799929","post","type-post","status-publish","format-standard","has-post-thumbnail","category-health","tag-au","tag-australia","tag-health"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts\/799929","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/comments?post=799929"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts\/799929\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/media\/799930"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/media?parent=799929"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/categories?post=799929"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/tags?post=799929"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}